Log In
Print this Print this

reVax (RGI-1001)

  Manage Alerts
Collapse Summary General Information
Company Regimmune Corp.
DescriptionA recombinant cedar antigen peptide encapsulated in a GalCer liposome
Molecular Target Natural killer T cells
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat cedar allergy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today